Novartis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.About NVS
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.
NVS Key Statistics
NVS News
Shares of Novartis fell in after-hours trading on Friday. Florence Lo / Reuters A highly anticipated cholesterol drug from Novartis NOVN -1.33 %decrease; down...
Novartis ( (NVS) ) has provided an announcement. On September 4, 2026, Novartis reported topline Phase III results from its Lp(a)HORIZON trial evaluating pelac...
Shares of Novartis declined in after-hours trading on Friday. Fabrice Coffrini / Agence France-Presse / Getty Images Novartis NOVN -1.33 %decrease; down pointi...
Analyst ratings
41%
of 29 ratingsMore NVS News
Technology Novartis, Ionis Tumble On Surprise Flop For Heart Drug Licensing Novartis (NVS) said late Friday its Ionis Pharmaceuticals (IONS)-partnered Lp(a) blo...
Ionis Pharmaceuticals (IONS) partner Novartis (NVS) announced that the pelacarsen Phase 3 Lp(a)HORIZON study, a pioneering cardiovascular outcomes trial, did no...
Investing This $3.2 Billion Novartis Bet Is Not a New Drug. It Is a Better Way to Take One Novartis just committed billions not to discover a new drug but to ch...
H.C. Wainwright reiterates a Buy rating on Halozyme (HALO) with a $115 price target after Novartis (NVS) signed an option and license agreement with Alteogen co...
Alteogen announced that it has entered into an option and license agreement with Novartis (NVS) for the development and commercialization of subcutaneous, SC, p...
Analyst Thibault Boutherin of Morgan Stanley maintained a Buy rating on Novartis AG, retaining the price target of CHF135.00. Thibault Boutherin has given his B...
Novartis AG (NYSE:NVS) stock climbed Tuesday after the Swiss drugmaker reported positive Phase 3 results for remibrutinib in relapsing multiple sclerosis. Remi...
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.